Ligand Pharma's market cap is currently ―. The company's EPS TTM is $2.9; its P/E ratio is 27.19; Ligand Pharma is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $0.89. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 32.87M	$ 26.37M	$ 17.15M	$ 27.05M	$ 66.09M
Gross Profit	$ 29.38M	$ 24.70M	$ 40.26M	$ 5.43M	$ 51.94M
EBIT	$ -12.14M	$ 3.46M	$ 55.78M	$ 55.15M	$ 1.19M
EBITDA	-	$ 12.20M	$ 64.71M	$ 53.93M	$ 14.69M
Net Income Common Stockholders	$ -10.27M	$ 2.29M	$ 43.61M	$ 10.66M	$ 404.00K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 190.50M	$ 219.04M	$ 282.67M	$ 211.87M	$ 121.41M
Total Assets	$ 769.23M	$ 758.11M	$ 811.08M	$ 762.67M	$ 1.05B
Total Debt	$ 6.33M	$ 11.67M	$ 88.68M	$ 87.75M	$ 113.89M
Net Debt	$ -184.17M	$ -207.37M	$ -193.99M	$ -124.12M	$ -7.52M
Total Liabilities	$ 101.33M	$ 93.21M	$ 164.76M	$ 165.18M	$ 234.31M
Stockholders Equity	$ 667.90M	$ 664.89M	$ 646.32M	$ 597.49M	$ 816.30M
Cash Flow	-
Free Cash Flow	-	$ -285.00K	$ 31.53M	$ 51.34M	$ 15.20M
Operating Cash Flow	$ 7.65M	$ -82.00K	$ 33.95M	$ 53.47M	$ 20.49M
Investing Cash Flow	$ -19.50M	$ 7.56M	$ 10.55M	$ -7.28M	$ 19.18M
Financing Cash Flow	$ 3.27M	$ -67.76M	$ -775.00K	$ -5.30M	$ -40.83M

Currency in USD

Ligand Pharma Earnings and Revenue History

Income Statement >

Ligand Pharma Debt to Assets

Balance Sheet >

Ligand Pharma Cash Flow

Cash Flow >

Ligand Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing